In addition, cancer cells are able to activate multiple immune checkpoint pathways that contribute to tumour immune escape, with programmed death protein 1 (PD-1) and programmed cell death ligand (PD-L1) considered to be the main immune checkpoint molecules [54]. This evidence concerns the gene CD274 and neoplasm.